Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06613022
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-18
Brief Title:
Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Grip Strength
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Grip Strength
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IASTM
Brief Summary:
The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization IASTM in healthy adult volunteers The main questions it aims to answer are
Does IASTM treatment have an effect on range of motion ROM as measured in the elbow wrist and thumb
Does IASTM treatment have an effect on grip strength Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change ROM andor grip strength
Participants will
Complete a questionnaire on medical history and injury background
Have elbow wrist and thumb range of motion ROM measurements taken on both upper extremities using a goniometer
Undergo grip strength testing using a JAMAR hand dynamometer in three positions on both upper extremities
Be randomly assigned to either IASTM first treatment group or the waitcontrol first group
Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the forearm wrist flexors and wrist extensors and the biceps and triceps using the HG8-Scanner tool and then the concave tool corresponding to the size of the structure being treated will be used HG6-Large Multi-Curve HG5-Medium Multi-Curve HG4-Small Multi-Curve in each direction for a total treatment time of 20 minutes for both upper extremities in all listed areas
Simply wait for 20 minutes the duration of time treatment with IASTM would require when assigned to the control group
Complete elbow wrist and thumb range of motion and grip strength measurement testing at the end of the first session
Return within fourteen days after the first session in order to undergo the opposite experience IASTM first means waitcontrol second and vice versa
Undergo the same baseline pre-test measurements for range of motion and grip strength as the first session
Experience the opposite treatment group for the same time period as the first session
Undergo the post-test range of motion and grip strength testing at the end of the second session for data comparison
Does IASTM treatment have an effect on range of motion ROM as measured in the elbow wrist and thumb
Does IASTM treatment have an effect on grip strength Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change ROM andor grip strength
Participants will
Complete a questionnaire on medical history and injury background
Have elbow wrist and thumb range of motion ROM measurements taken on both upper extremities using a goniometer
Undergo grip strength testing using a JAMAR hand dynamometer in three positions on both upper extremities
Be randomly assigned to either IASTM first treatment group or the waitcontrol first group
Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the forearm wrist flexors and wrist extensors and the biceps and triceps using the HG8-Scanner tool and then the concave tool corresponding to the size of the structure being treated will be used HG6-Large Multi-Curve HG5-Medium Multi-Curve HG4-Small Multi-Curve in each direction for a total treatment time of 20 minutes for both upper extremities in all listed areas
Simply wait for 20 minutes the duration of time treatment with IASTM would require when assigned to the control group
Complete elbow wrist and thumb range of motion and grip strength measurement testing at the end of the first session
Return within fourteen days after the first session in order to undergo the opposite experience IASTM first means waitcontrol second and vice versa
Undergo the same baseline pre-test measurements for range of motion and grip strength as the first session
Experience the opposite treatment group for the same time period as the first session
Undergo the post-test range of motion and grip strength testing at the end of the second session for data comparison
Detailed Description:
No further information to note than what is described in the summary or elsewhere
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None